Metastatic Breast Cancer Clinical Trials
Metastatic Breast Cancer studies recruiting patients for novel treatments. Filter by phase, distance, and inclusion criteria to find your perfect metastatic breast cancer clinical trial.
Condition
Metastatic Breast Cancer
Location
Distance
10 miles
50 miles
Any
Age
Search
Clinical Trials
Metastatic Breast Cancer Clinical Trials
Phase-Based Estimates
2
Effectiveness
3
Safety
Prednisone Or Prednisolone
for Urogenital Neoplasms
Tucson, AZ
18+
Male
Phase 3
Recruiting
Metastatic
Tucson, AZ
18+
Male
The purpose of this study is to learn whether adding abemaciclib to abiraterone plus prednisone prolongs the time before prostate cancer gets worse. Participation may last approximately 60 months.
Phase-Based Estimates
1
Effectiveness
2
Safety
Reparixin
for Breast Cancer
Cary, NC
18+
All Sexes
Phase 2
Recruiting
Locally Advanced
Cary, NC
18+
All Sexes
Primary objective: • To assess the efficacy of reparixin compared to placebo in limiting CRF in adult patients with locally advanced or metastatic breast cancer undergoing single-agent taxane chemotherapy, using FACITFatigue scale. The secondary objectives are: To evaluate change in Quality of Life in the two treatment arms To assess the percentage of patients treated with reparixin compared to placebo delaying and discontinuing chemotherapy To assess Patient Global Impression of Severity (PGI-S) score and Patient Global Impression of Change (PGI-C) score associated with reparixin compared to placebo To assess the effect of reparixin compared to placebo on ECOG PS To assess the effects of reparixin vs placebo on Objective Response Rate (ORR), Progression Free Survival (PFS), Overall Survival (OS) The safety objective is: • To assess the safety and tolerability of reparixin in adult patients undergoing taxane-containing chemotherapy. The pharmacokinetic (PK) objective is: • To define the PK profile of orally administered reparixin, its metabolites (DF2243Y, DF2188Y, ibuprofen) and concomitant antineoplastic agents (paclitaxel, or nab-paclitaxel or docetaxel) in adult patients with locally advanced or metastatic breast cancer.
Phase-Based Estimates
1
Effectiveness
1
Safety
EMB-01
for Gastrointestinal Neoplasms
Houston, TX
18+
All Sexes
Phase 1 & 2
Recruiting
Locally Advanced
Houston, TX
18+
All Sexes
This study is to evaluate the safety and antitumor activity of EMB-01 in advanced/metastatic gastrointestinal cancers, including gastric cancer, hepatocellular cancer, cholangiocarcinoma and colorectal cancer.
Phase-Based Estimates
2
Effectiveness
3
Safety
Abemaciclib
for Breast Cancer
Los Angeles, CA
18+
All Sexes
Phase 3
Recruiting
Locally Advanced
Los Angeles, CA
18+
All Sexes
This study will evaluate the effect of adding abemaciclib to fulvestrant for the treatment of hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer that progressed or recurred after previous treatment with a type of drug known as a CDK4/6 inhibitor and endocrine therapy. Participation could last up to 5 years, depending on how you and your tumor respond.
Phase-Based Estimates
1
Effectiveness
2
Safety
Nab-sirolimus
for Neoplasm Metastasis
Belleville, NJ
Any Age
All Sexes
Phase 2
Recruiting
Locally Advanced
Belleville, NJ
Any Age
All Sexes
This study is evaluating whether a drug called ABI-009 can help treat a type of cancer called tuberous sclerosis complex.
Phase-Based Estimates
1
Effectiveness
1
Safety
Stereotactic Radiosurgery
for Cancer, Second Primary
Detroit, MI
18+
All Sexes
Recruiting
Metastatic
Detroit, MI
18+
All Sexes
This study is evaluating whether a combination of spinal interstitial laser ablation and stereotactic spine radiosurgery is more effective than either treatment alone.
Phase-Based Estimates
2
Effectiveness
3
Safety
LY3484356
for Neoplasm Metastasis
Coon Rapids, MN
18+
All Sexes
Phase 3
Recruiting
Locally Advanced
Coon Rapids, MN
18+
All Sexes
This study is evaluating whether a drug called LY3484356 can help treat breast cancer.
Phase-Based Estimates
1
Effectiveness
1
Safety
BI 1810631
for Neoplasm Metastasis
Houston, TX
18+
All Sexes
Phase 1
Recruiting
Grade I
Houston, TX
18+
All Sexes
This study is evaluating whether a medicine called BI 1810631 can shrink tumours in people with advanced cancer.
Phase-Based Estimates
1
Effectiveness
1
Safety
V937
for Neoplasm Metastasis
Toronto, Canada
18+
All Sexes
Phase 1 & 2
Recruiting
Locally Advanced
Toronto, Canada
18+
All Sexes
This study is evaluating whether a combination of two drugs may help treat cancer.
Phase-Based Estimates
1
Effectiveness
1
Safety
PF-07265807
for Neoplasm Metastasis
Indianapolis, IN
18+
All Sexes
Phase 1
Recruiting
Locally Advanced
Indianapolis, IN
18+
All Sexes
This study is evaluating whether a drug may help treat cancer.
Phase-Based Estimates
1
Effectiveness
1
Safety
Microwave Ablation
for Lung Cancer
Calgary, Canada
18+
All Sexes
Phase 1 & 2
Recruiting
Locally Advanced
Calgary, Canada
18+
All Sexes
This study is evaluating whether a surgery which reduces blood flow in a stomach artery leads to significant weightloss.
Phase-Based Estimates
1
Effectiveness
1
Safety
Survey-based Patient/Clinician Jumpstart
for Neoplasm Metastasis
Seattle, WA
18+
All Sexes
Recruiting
Locally Advanced
Seattle, WA
18+
All Sexes
This study is evaluating whether a survey-based patient/clinician Jumpstart guide improves quality of care for patients with chronic illness.
Phase-Based Estimates
1
Effectiveness
1
Safety
EHR-based Clinician Jumpstart
for Kidney Failure
Seattle, WA
18+
All Sexes
Waitlist Available
Locally Advanced
Seattle, WA
18+
All Sexes
This study is evaluating whether a clinician-led intervention may help improve the quality of care for patients with chronic illness.
Phase-Based Estimates
1
Effectiveness
1
Safety
IK-175 And Nivolumab
for Carcinoma
Gilbert, AZ
18+
All Sexes
Phase 1
Recruiting
Locally Advanced
Gilbert, AZ
18+
All Sexes
This study is evaluating whether a drug may help treat advanced or metastatic solid tumors.
Phase-Based Estimates
1
Effectiveness
1
Safety
V938
for Neoplasm Metastasis
Toronto, Canada
18+
All Sexes
Phase 1
Waitlist Available
Locally Advanced
Toronto, Canada
18+
All Sexes
This study is evaluating whether a combination of two drugs may help treat cancer.
Phase-Based Estimates
1
Effectiveness
1
Safety
EMB-01
for Neoplasm Metastasis
Boston, MA
18+
All Sexes
Phase 1 & 2
Recruiting
Grade I
Boston, MA
18+
All Sexes
This study is evaluating whether a drug called EMB-01 may help treat solid tumors.
Phase-Based Estimates
1
Effectiveness
2
Safety
Bempegaldesleukin
for Urinary Bladder Cancer
Toronto, Canada
18+
All Sexes
Phase 2
Waitlist Available
Locally Advanced
Toronto, Canada
18+
All Sexes
This study is evaluating whether a drug called NKTR-214 can help treat cancer.
Phase-Based Estimates
1
Effectiveness
1
Safety
Facilitator-Based Intervention
for Cancer
Seattle, WA
18+
All Sexes
Recruiting
Grade III
Seattle, WA
18+
All Sexes
This study is evaluating whether a nurse facilitator can help patients and their families communicate with their doctors and nurses to help them get the care they want.
Phase-Based Estimates
1
Effectiveness
2
Safety
BI 754091
for Neoplasm Metastasis
Covington, LA
18+
All Sexes
Phase 2
Waitlist Available
Locally Advanced
Covington, LA
18+
All Sexes
This is a study in adults with various types of advanced cancer. The purpose of the study is to test a medicine called BI 754091 in combination with several other cancer medicines. BI 754091 is an immunotherapy. This means it may help the immune system fight cancer. Such therapies are also called immune checkpoint inhibitors. How long the participants are in the study depends on whether they benefit from treatment and whether they experience unacceptable side effects. The participants are put into different groups. Each group receives BI 754091 in combination with another medicine. The doctors check whether the tumors shrink or disappear. The doctors also check the general health of the participants.
Phase-Based Estimates
1
Effectiveness
1
Safety
Paclitaxel.
for Sarcoma
Nashville, TN
18+
All Sexes
Phase 1 & 2
Recruiting
Locally Advanced
Nashville, TN
18+
All Sexes
This study is evaluating whether a drug which blocks a certain protein may help treat cancer.
Phase-Based Estimates
1
Effectiveness
1
Safety
MRX-2843
for Pathologic Processes
Chapel Hill, NC
18+
All Sexes
Phase 1
Recruiting
Locally Advanced
Chapel Hill, NC
18+
All Sexes
This study is evaluating whether a drug may help treat cancer.
Phase-Based Estimates
1
Effectiveness
1
Safety
Subcutaneous (SC) SEA-CD40
for Cancer
Chapel Hill, NC
18+
All Sexes
Phase 1
Waitlist Available
Grade I
Chapel Hill, NC
18+
All Sexes
This study is evaluating whether SEA-CD40 is safe and effective when given alone, in combination with pembrolizumab, and in combination with pembrolizumab, gemcitabine, and nab-paclitaxel
Phase-Based Estimates
1
Effectiveness
1
Safety
Neratinib
for Breast Cancer
Houston, TX
18+
All Sexes
Phase 1 & 2
Waitlist Available
Grade I
Houston, TX
18+
All Sexes
This study is to learn if the combination therapy of capmatinib and neritinib can help to control metastatic or locally advanced breast cancer. Researchers also want to find the highest tolerable dose of the combination therapy of capmatinib and neritinib that can be used in this study drug combinations. The safety of this drug combination and the CELsignia MP test methodology will also be studied.
Phase-Based Estimates
1
Effectiveness
1
Safety
Fulvestrant
for Breast Carcinoma
Anaheim, CA
18+
All Sexes
Phase 1 & 2
Recruiting
Locally Advanced
Anaheim, CA
18+
All Sexes
NUV-422-03 is a randomized, non-comparative Phase 1/2 dose escalation and expansion study designed to evaluate the safety and efficacy of NUV-422 in combination with fulvestrant relative to NUV-422 monotherapy and fulvestrant monotherapy. The study population is comprised of adults with HR+HER2- aBC. Patients will self-administer NUV-422 orally in 28-day cycles and receive 500 mg fulvestrant intramuscularly (IM) on Days 1 and 15 of Cycle 1 and Day 1 of every cycle thereafter. Patients will be treated until disease progression, toxicity, withdrawal of consent, or termination of the study.
Phase-Based Estimates
1
Effectiveness
2
Safety
Dapagliflozin 10Mg Tab
for Breast Cancer
Kansas City, MO
18+
All Sexes
Phase 2
Recruiting
Grade I
Kansas City, MO
18+
All Sexes
This study is evaluating whether a drug called dapagliflozin can be used to treat breast cancer.
Phase-Based Estimates
1
Effectiveness
1
Safety
Fulvestrant
for Breast Cancer
Uniondale, NY
18+
All Sexes
Phase 1
Recruiting
Locally Advanced
Uniondale, NY
18+
All Sexes
This study is evaluating whether a drug which is designed to target cancer cells may help treat breast cancer.
Phase-Based Estimates
1
Effectiveness
1
Safety
NUV-422
for Glioma
Tyler, TX
18+
All Sexes
Phase 1 & 2
Waitlist Available
Locally Advanced
Tyler, TX
18+
All Sexes
This study is evaluating whether a drug may help treat brain tumors.
Phase-Based Estimates
1
Effectiveness
1
Safety
Precision Medicine
for Breast Cancer
Salt Lake City, UT
18+
All Sexes
Recruiting
Locally Advanced
Salt Lake City, UT
18+
All Sexes
This study is evaluating whether genomic sequencing and drug screening may help select the best treatment for metastatic breast cancer.
Phase-Based Estimates
1
Effectiveness
1
Safety
Capecitabine
for Triple Negative Breast Neoplasms
Gainesville, FL
18+
All Sexes
Phase 1 & 2
Recruiting
High Risk
Gainesville, FL
18+
All Sexes
This study is evaluating whether a new treatment may help eliminate minimal residual disease in triple negative breast cancer.
Phase-Based Estimates
1
Effectiveness
1
Safety
FES PET/CT
for Breast Cancer
Madison, WI
18+
All Sexes
Phase < 1
Recruiting
Metastatic
Madison, WI
18+
All Sexes
This study is evaluating whether a new imaging technique can help determine the optimal dose of tamoxifen for patients with ESR1 mutations.
Phase-Based Estimates
1
Effectiveness
2
Safety
Sitravatinib
for Breast Cancer
Houston, TX
18+
All Sexes
Phase 2
Recruiting
Locally Advanced
Houston, TX
18+
All Sexes
This study is evaluating whether a drug called sitravatinib can help treat breast cancer.
Phase-Based Estimates
1
Effectiveness
1
Safety
Abraxane
for Breast Cancer
Houston, TX
18+
All Sexes
Phase 1 & 2
Recruiting
Grade I
Houston, TX
18+
All Sexes
This study is evaluating whether a drug may help treat cancer.
Phase-Based Estimates
1
Effectiveness
2
Safety
Therapeutic Estradiol
for Breast Cancer
San Francisco, CA
18+
Female
Phase 2
Recruiting
Locally Advanced
San Francisco, CA
18+
Female
This study is evaluating whether a hormone called estrogen may help treat breast cancer.
Phase-Based Estimates
1
Effectiveness
2
Safety
Capecitabine
for Breast Cancer
Houston, TX
18+
All Sexes
Phase 2
Waitlist Available
Grade I
Houston, TX
18+
All Sexes
This study is evaluating whether a combination of drugs may help treat breast cancer that has spread to the brain.
Phase-Based Estimates
1
Effectiveness
1
Safety
Niraparib
for Breast Cancer
Philadelphia, PA
18+
Female
Phase 1 & 2
Recruiting
Metastatic
Philadelphia, PA
18+
Female
This study is evaluating whether a new drug combination may help treat breast cancer.
Phase-Based Estimates
1
Effectiveness
2
Safety
Simvastatin 80mg
for Breast Cancer
Houston, TX
18+
Female
Phase 2
Recruiting
Metastatic
Houston, TX
18+
Female
This study is evaluating whether a statin drug may help breast cancer patients respond to anti-HER2 therapy.
Phase-Based Estimates
2
Effectiveness
3
Safety
Atezolizumab
for Adenocarcinoma
Columbus, OH
18+
All Sexes
Phase 3
Waitlist Available
Grade I
Columbus, OH
18+
All Sexes
This study is evaluating whether a combination of drugs may help treat breast cancer.
Phase-Based Estimates
2
Effectiveness
3
Safety
Palbociclib
for Breast Cancer
Harvey, IL
18+
All Sexes
Phase 3
Waitlist Available
Metastatic
Harvey, IL
18+
All Sexes
This study is evaluating whether a combination of drugs may help treat breast cancer.
Phase-Based Estimates
1
Effectiveness
1
Safety
Cirmtuzumab + Paclitaxel
for Breast Cancer
La Jolla, CA
18+
All Sexes
Phase 1
Waitlist Available
Grade I
La Jolla, CA
18+
All Sexes
This study is evaluating whether a drug which targets a protein on the surface of breast cancer cells may help treat breast cancer.
Phase-Based Estimates
1
Effectiveness
2
Safety
Miracle Mouthwash Plus Hydrocortisone
for Cancer
US, TX
18+
Female
Phase 2
Waitlist Available
Grade II
US, TX
18+
Female
This study is evaluating whether a steroid-based mouth rinse can prevent or treat mouth sores in patients taking an aromatase inhibitor plus everolimus.
Phase-Based Estimates
1
Effectiveness
2
Safety
Alisertib
for Breast Cancer
Including Dallas And Austin, TX
18+
Female
Phase 2
Waitlist Available
Grade III
Including Dallas And Austin, TX
18+
Female
This study is evaluating whether a drug called alisertib in combination with paclitaxel can shrink or slow tumor growth in women with hormone receptor (HR)-positive, HER2-negative or HR-negative, HER2-negative (tri
Phase-Based Estimates
1
Effectiveness
1
Safety
PI3K Inhibitor BYL719
for Carcinoma Breast Stage IV
Nashville, TN
18+
Female
Phase 1
Waitlist Available
Grade II
Nashville, TN
18+
Female
This study is evaluating the side effects and best dose of the PI3K inhibitor BYL719 when given together with letrozole in treating patients with hormone receptor-positive metastatic breast cancer.
Phase-Based Estimates
1
Effectiveness
2
Safety
ABT-888
for Breast Cancer
Boston, MA
18+
All Sexes
Phase 2
Waitlist Available
Locally Advanced
Boston, MA
18+
All Sexes
This study is evaluating whether the combination of ABT-888 and temozolomide is safe and effective in treating patients with metastatic breast cancer.
Phase-Based Estimates
1
Effectiveness
1
Safety
Lapatinib, Docetaxel, Trastuzumab
for Breast Cancer
Nashville, TN
18+
All Sexes
Phase 1
Waitlist Available
Metastatic
Nashville, TN
18+
All Sexes
This study was designed to find the optimal (best) doses of GW572016, docetaxel, and trastuzumab when given together.
Phase-Based Estimates
1
Effectiveness
2
Safety
Fulvestrant Run-In
for ER-Positive Breast Cancer
Houston, TX
18+
Female
Phase 2
Recruiting
Grade II
Houston, TX
18+
Female
The study will investigate if a one month drug holiday from the CDK4/6 inhibitor drug, abemaciclib, will restore the body's sensitivity to the drug and make the subsequent treatment of abemaciclib plus fulvestrant more effective.
Phase-Based Estimates
1
Effectiveness
2
Safety
Pembrolizumab
for Cancer
Kansas City, MO
18+
All Sexes
Phase 2
Recruiting
Grade I
Kansas City, MO
18+
All Sexes
The primary objective of this Phase 2 Simon 2-Stage study is to determinate the Overall Response Rate (ORR) per RECIST v1.1 following treatment with Imprime PGG + pembrolizumab in patients with ER/PR+/ HER2(-) metastatic breast cancer who have progressed through prior hormone therapy with at least one CDK4/6 inhibitor, and a maximum of 2 subsequent chemotherapy treatment. Patients will be screened for baseline anti-β glucan antibody level (ABA; measured in peripheral blood). Those patients with an ABA greater than or equal to 20 mcg/ml and meeting all other I/E criteria, will be enrolled. The study will enroll 47 patients with 23 patients enrolled into Stage 1. If 4 or more patients in Stage 1 have an objective response after 12 weeks of treatment, the study will proceed into Stage 2. A total of 24 patients will be enrolled in Stage 2 for a total combined population of 47. Overall, objective responses must be observed in 10 patients for the study to be declared a success.
Phase-Based Estimates
1
Effectiveness
1
Safety
Immunocytokine NHS-IL12
for Prognostic Stage IV Breast Cancer AJCC v8
Houston, TX
18+
All Sexes
Phase 1
Recruiting
Metastatic
Houston, TX
18+
All Sexes
This study is evaluating whether NHS-IL12, bintrafusp alfa, and radiation therapy may be a safe and effective treatment for patients with hormone receptor positive, HER2 negative breast cancer that has spread to other places in the body (metastatic).
Phase-Based Estimates
1
Effectiveness
2
Safety
Giredestrant
for Breast Cancer
Marietta, GA
18+
All Sexes
Phase 2
Waitlist Available
Locally Advanced
Marietta, GA
18+
All Sexes
This study is evaluating whether a drug called giredestrant may help treat breast cancer.
Phase-Based Estimates
1
Effectiveness
2
Safety
18F-DCFPyL
for Breast Cancer
Madison, WI
18+
All Sexes
Phase 2
Recruiting
Metastatic
Madison, WI
18+
All Sexes
This study is evaluating whether a protein found in prostate cancer may also be found in breast cancer and may be a factor in resistance to anti-androgen therapies.
Phase-Based Estimates
1
Effectiveness
1
Safety
LY3484356
for Endometrial Neoplasms
The Woodlands, TX
18+
All Sexes
Phase 1
Recruiting
Locally Advanced
The Woodlands, TX
18+
All Sexes
This study is evaluating whether a drug may help treat breast and endometrial cancer.
Phase-Based Estimates
1
Effectiveness
2
Safety
Futibatinib Plus Fulvestrant
for Breast Cancer
Calgary, Canada
18+
All Sexes
Phase 2
Recruiting
Locally Advanced
Calgary, Canada
18+
All Sexes
This study is evaluating whether a drug may help treat breast cancer.
Phase-Based Estimates
1
Effectiveness
1
Safety
Ipatasertib
for Breast Cancer
Boston, MA
18+
Female
Phase 1
Recruiting
Locally Advanced
Boston, MA
18+
Female
This study is evaluating whether a combination of drugs may be effective for treating breast cancer.
Phase-Based Estimates
1
Effectiveness
1
Safety
Palbociclib
for Breast Cancer
Overland Park, KS
18+
Female
Phase 1 & 2
Waitlist Available
Locally Advanced
Overland Park, KS
18+
Female
This study is evaluating the recommended dose of palbociclib in combination with letrozole and another medication, Ado-trastuzumab emtansine (T-DM1). Additionally, researchers will determine how well this
Phase-Based Estimates
1
Effectiveness
2
Safety
CFI-400945
for Breast Cancer
Toronto, Canada
18+
Female
Phase 2
Recruiting
Locally Advanced
Toronto, Canada
18+
Female
This study is evaluating whether chemotherapy can be used to treat cancer.
Phase-Based Estimates
1
Effectiveness
2
Safety
Ribociclib
for Breast Cancer
Lancaster, CA
65+
All Sexes
Phase 2
Waitlist Available
Metastatic
Lancaster, CA
65+
All Sexes
This study is evaluating whether ribociclib and aromatase inhibitors are safe and effective in treating participants with hormone receptor positive breast cancer that has spread to other places in the body.
Phase-Based Estimates
1
Effectiveness
1
Safety
Ibrutinib 420 Mg
for Breast Cancer
Dallas, TX
18+
Female
Phase 1 & 2
Recruiting
Metastatic
Dallas, TX
18+
Female
This study is evaluating whether a combination of two drugs may help treat breast cancer.
Phase-Based Estimates
1
Effectiveness
2
Safety
Neratinib
for Breast Cancer
Brewer, ME
18+
Female
Phase 2
Waitlist Available
Locally Advanced
Brewer, ME
18+
Female
This study is evaluating whether a drug called Neratinib with and without Fulvestrant as possible treatments for HER2-positive breast cancer.
Phase-Based Estimates
1
Effectiveness
1
Safety
Enzalutamide
for Triple Negative Breast Carcinoma
Houston, TX
18+
All Sexes
Phase 1
Recruiting
Houston, TX
18+
All Sexes
This study is evaluating whether a combination of two drugs may be more effective than either drug alone in treating breast cancer.
Phase-Based Estimates
1
Effectiveness
2
Safety
Abemaciclib
for Breast Cancer
Boston, MA
18+
All Sexes
Phase 2
Waitlist Available
Grade I
Boston, MA
18+
All Sexes
This study is evaluating whether a drug may help treat breast cancer.
Phase-Based Estimates
1
Effectiveness
2
Safety
Abemaciclib
for Breast Cancer
Fort Worth, TX
18+
Female
Phase 2
Waitlist Available
Grade I
Fort Worth, TX
18+
Female
This study is evaluating whether a drug called abemaciclib can be used to treat breast cancer.
Phase-Based Estimates
1
Effectiveness
2
Safety
Pembrolizumab
for Carcinoma Breast Stage IV
Lancaster, CA
18+
All Sexes
Phase 2
Waitlist Available
Metastatic
Lancaster, CA
18+
All Sexes
This study is evaluating whether pembrolizumab and doxorubicin hydrochloride works better than pembrolizumab with anti-estrogen therapy in treating patients with triple-negative or hormone-receptor positive breast
Phase-Based Estimates
2
Effectiveness
3
Safety
Margetuximab
for Neoplasm Metastasis
Goodyear, AZ
18+
All Sexes
Phase 3
Waitlist Available
Grade I
Goodyear, AZ
18+
All Sexes
This study is evaluating whether a new drug called margetuximab can be used to treat breast cancer.
Phase-Based Estimates
1
Effectiveness
2
Safety
Everolimus
for Breast Cancer
Los Angeles, CA
18+
Female
Phase 2
Waitlist Available
Metastatic
Los Angeles, CA
18+
Female
This study is evaluating whether radium 223 dichloride can be used to treat breast cancer.
Phase-Based Estimates
2
Effectiveness
3
Safety
Palbociclib
for Breast Cancer
Los Angeles, CA
18+
Female
Phase 3
Waitlist Available
Locally Advanced
Los Angeles, CA
18+
Female
This study is evaluating whether a drug called palbociclib can improve the survival of women with breast cancer.
Phase-Based Estimates
1
Effectiveness
1
Safety
AZD2014
for Breast Cancer
Nashville, TN
18+
Female
Phase 1
Waitlist Available
Locally Advanced
Nashville, TN
18+
Female
This study is evaluating whether a drug called AZD2014 is safe and tolerable when given in combination with a drug called Fulvestrant.
Phase-Based Estimates
1
Effectiveness
1
Safety
Fulvestrant
for Breast Cancer
Aurora, CO
18+
All Sexes
Phase 1 & 2
Waitlist Available
Locally Advanced
Aurora, CO
18+
All Sexes
Phase IB/II clinical trial of Alpelisb and Tucatinib in patients with PIK3CA-Mutant HER2-positive metastatic breast cancer.
Phase-Based Estimates
1
Effectiveness
1
Safety
DiviTum® TKa Assay
for Breast Cancer
Saint Louis, MO
18+
All Sexes
Recruiting
Locally Advanced
Saint Louis, MO
18+
All Sexes
This study is evaluating whether a blood test can predict which patients with metastatic breast cancer will have a better response to treatment.
Phase-Based Estimates
1
Effectiveness
2
Safety
ARX788
for Breast Cancer
Tyler, TX
18+
All Sexes
Phase 2
Recruiting
Metastatic
Tyler, TX
18+
All Sexes
This study is evaluating whether a drug may help treat breast cancer.
Phase-Based Estimates
1
Effectiveness
2
Safety
U3-1402
for Breast Cancer
Charlotte, NC
18+
All Sexes
Phase 2
Recruiting
Locally Advanced